A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

Clinical trial NCT00106431 · COMPLETED

Trial details

NCT number: NCT00106431
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma

Start date: 2005-01-01
Primary completion: 2008-06-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.